التفاصيل البيبلوغرافية
| العنوان: |
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes ... |
| المؤلفون: |
Lilly |
| بيانات النشر: |
Vivli |
| سنة النشر: |
2023 |
| المجموعة: |
DataCite Metadata Store (German National Library of Science and Technology) |
| مصطلحات موضوعية: |
Conditions Type 2 Diabetes, Interventions Tirzepatide, Interventions Semaglutide |
| الوصف: |
The reason for this study is to compare the effect of the study drug tirzepatide to semaglutide on blood sugar levels in participants with type 2 diabetes. The study will last approximately 47 weeks and may include about 12 visits. ... |
| نوع الوثيقة: |
dataset |
| اللغة: |
unknown |
| DOI: |
10.25934/pr00008970 |
| الإتاحة: |
https://doi.org/10.25934/pr00008970Test |
| حقوق: |
Study data may be accessed by completing a request form at https://vivli.orgTest. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembersTest/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreementTest/ |
| رقم الانضمام: |
edsbas.63DF3AB0 |
| قاعدة البيانات: |
BASE |
